Search Results - "Arnon, Ruth"
-
1
Astrocytes in Multiple Sclerosis—Essential Constituents with Diverse Multifaceted Functions
Published in International journal of molecular sciences (31-05-2021)“…In multiple sclerosis (MS), astrocytes respond to the inflammatory stimulation with an early robust process of morphological, transcriptional, biochemical, and…”
Get full text
Journal Article -
2
Amyloid Precursor Protein and Tau Peptides Linked Together Ameliorate Loss of Cognition in an Alzheimer's Disease Animal Model
Published in International journal of molecular sciences (01-08-2023)“…The major proteins involved in Alzheimer's disease (AD) are amyloid precursor protein (APP) and Tau. We demonstrate that APP1 (390-412) and Tau1 (19-34),…”
Get full text
Journal Article -
3
Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis
Published in Glia (01-05-2018)“…To elucidate mechanisms contributing to cortical pathology in multiple sclerosis (MS), we investigated neurovascular aberrations, in particular the association…”
Get full text
Journal Article -
4
Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis
Published in International journal of molecular sciences (14-12-2021)“…Axonal and neuronal pathologies are a central constituent of multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE),…”
Get full text
Journal Article -
5
Peptide Interference with APP and Tau Association: Relevance to Alzheimer's Disease Amelioration
Published in International journal of molecular sciences (05-05-2020)“…The two major proteins involved in Alzheimer's disease (AD) are the amyloid precursor protein (APP) and Tau. Here, we demonstrate that these two proteins can…”
Get full text
Journal Article -
6
Mechanism of Action of Glatiramer Acetate in Multiple Sclerosis and Its Potential for the Development of New Applications
Published in Proceedings of the National Academy of Sciences - PNAS (05-10-2004)“…Glatiramer acetate (GA, Copaxone, Copolymer 1) is an approved drug for the treatment of multiple sclerosis and is highly effective in the suppression of…”
Get full text
Journal Article -
7
Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate
Published in Journal of Neural Transmission (01-11-2009)“…It is by now established that multiple sclerosis (MS) is not simply an autoimmune disease and that in addition to inflammation and demyelination, axonal injury…”
Get full text
Journal Article -
8
Chromatin conformation governs T-cell receptor Jβ gene segment usage
Published in Proceedings of the National Academy of Sciences - PNAS (25-09-2012)“…T cells play fundamental roles in adaptive immunity, relying on a diverse repertoire of T-cell receptor (TCR) α and β chains. Diversity of the TCR β chain is…”
Get full text
Journal Article -
9
Astrocyte morphology is confined by cortical functional boundaries in mammals ranging from mice to human
Published in eLife (10-06-2016)“…Cortical blood flow can be modulated by local activity across a range of species; from barrel-specific blood flow in the rodent somatosensory cortex to the…”
Get full text
Journal Article -
10
Distinct pathological patterns in relapsing–remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate
Published in Journal of autoimmunity (01-11-2011)“…Abstract The respective roles of inflammatory and neurodegenerative processes in the pathology of multiple sclerosis (MS) and in its animal model experimental…”
Get full text
Journal Article -
11
Neurogenesis and Neuroprotection Induced by Peripheral Immunomodulatory Treatment of Experimental Autoimmune Encephalomyelitis
Published in The Journal of neuroscience (07-09-2005)“…Brain insults such as the autoimmune inflammatory process in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE) induce a measure of…”
Get full text
Journal Article -
12
The Immunomodulator Glatiramer Acetate Augments the Expression of Neurotrophic Factors in Brains of Experimental Autoimmune Encephalomyelitis Mice
Published in Proceedings of the National Academy of Sciences - PNAS (27-12-2005)“…Neurotrophins (NTs) such as BDNF, NT-3, and NT-4 are important modulators of neuronal function and survival. Their expression in the CNS after various insults…”
Get full text
Journal Article -
13
Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis
Published in Proceedings of the National Academy of Sciences - PNAS (12-08-2008)“…The interplay between demyelination and remyelination is critical in the progress of multiple sclerosis (MS) and its animal model, experimental autoimmune…”
Get full text
Journal Article -
14
Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate
Published in Experimental neurology (01-02-2013)“…The roles of inflammation and degeneration as well as of gray matter abnormalities in multiple sclerosis (MS) and its animal model experimental autoimmune…”
Get full text
Journal Article -
15
Glatiramer Acetate-Specific T Cells in the Brain Express T Helper 2/3 Cytokines and Brain-Derived Neurotrophic Factor in situ
Published in Proceedings of the National Academy of Sciences - PNAS (25-11-2003)“…The ability of a remedy to modulate the pathological process in the target organ is crucial for its therapeutic activity. Glatiramer acetate (GA, Copaxone,…”
Get full text
Journal Article -
16
A DNA Aptamer Prevents Influenza Infection by Blocking the Receptor Binding Region of the Viral Hemagglutinin
Published in The Journal of biological chemistry (12-11-2004)“…Influenza A virus infection is a major source of morbidity and mortality worldwide. Current means of control for influenza are based on prophylaxis by vaccines…”
Get full text
Journal Article -
17
Neurogenesis and neuroprotection in the CNS--fundamental elements in the effect of Glatiramer acetate on treatment of autoimmune neurological disorders
Published in Molecular neurobiology (01-12-2007)“…Multiple sclerosis (MS) is no longer considered to be simply an autoimmune disease. In addition to inflammation and demyelination, axonal injury and neuronal…”
Get full text
Journal Article -
18
Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis
Published in Frontiers in chemistry (20-06-2022)“…The involvement of Myelin Basic Protein (MBP) in Multiple Sclerosis (MS) has been widely discussed in the literature. This intrinsically disordered protein has…”
Get full text
Journal Article -
19
Specific Th2 Cells Accumulate in the Central Nervous System to Mice Protected against Experimental Autoimmune Encephalomyelitis by Copolymer 1
Published in Proceedings of the National Academy of Sciences - PNAS (10-10-2000)“…This study addresses the issue of the effect of immunomodulating therapies in the target organ--the central nervous system (CNS)--in the case of multiple…”
Get full text
Journal Article -
20
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease
Published in The Journal of pharmacology and experimental therapeutics (01-07-2006)“…Inflammatory bowel disease (IBD) is characterized by detrimental immune reactivity in the gut and imbalance between proinflammatory and anti-inflammatory…”
Get more information
Journal Article